HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Familial progressive supranuclear palsy
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Disease Context: Research Results
Nervous System Diseases: 14178
Neurodegenerative Diseases: 42472
Tauopathies: 2793
Progressive Supranuclear Palsy: 1232
Familial progressive supranuclear palsy: 1
Neurologic Manifestations: 7102
Paralysis: 14164
Ophthalmoplegia: 867
Progressive Supranuclear Palsy: 1232
Familial progressive supranuclear palsy: 1
Central Nervous System Diseases: 4213
Brain Diseases: 15694
Basal Ganglia Diseases: 346
Progressive Supranuclear Palsy: 1232
Familial progressive supranuclear palsy: 1
Movement Disorders: 4634
Progressive Supranuclear Palsy: 1232
Familial progressive supranuclear palsy: 1
Cranial Nerve Diseases: 554
Ocular Motility Disorders: 514
Ophthalmoplegia: 867
Progressive Supranuclear Palsy: 1232
Familial progressive supranuclear palsy: 1
Eye Diseases: 3522
Ocular Motility Disorders: 514
Ophthalmoplegia: 867
Progressive Supranuclear Palsy: 1232
Familial progressive supranuclear palsy: 1
Signs and Symptoms Pathological Conditions
Signs and Symptoms
Neurologic Manifestations: 7102
Paralysis: 14164
Ophthalmoplegia: 867
Progressive Supranuclear Palsy: 1232
Familial progressive supranuclear palsy: 1
Experts
1.
Ahsan, R L
: 1 article (03/2007)
2.
Brooks, D J
: 1 article (03/2007)
3.
Pavese, N
: 1 article (03/2007)
4.
Piccini, P
: 1 article (03/2007)
5.
Tai, Y F
: 1 article (03/2007)
6.
de Yébenes, J G
: 1 article (03/2007)
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Familial progressive supranuclear palsy:
1.
fluorodopa F 18
IBA
03/01/2007 - "
We analyzed (18)F-dopa PET data from 11 members of kindreds with familial progressive supranuclear palsy (PSP) to characterize their cerebral dopaminergic dysfunction.
"